AGP Executive Report
Last update: 9 hours agoFDA Watch: FDA cleared United Therapeutics to proceed with its pig-derived, gene-edited UHeart xenotransplant trial (EXPRESS), with early safety/efficacy data guiding expansion. Biopharma Updates: Agenus published Phase 1b botensilimab + balstilimab results in treatment-refractory liver cancer, while Emcure Pharma disclosed a USFDA Form 483 with seven observations after a Gujarat plant inspection—calling them procedural and moving to corrective actions. Defense & Tech: The U.S. is accelerating its “Golden Dome” homeland missile defense planning as officials warn hypersonics, swarms, and cyber could overwhelm current systems. Auto/Markets: Morgan Stanley turned bullish on Ford’s EV storage business, driving a sharp stock jump. Telecom: Verizon raised prices on its Unlimited Ultimate plan and then rolled out “generous” offers to soften the blow. Local/Infrastructure: Forest Service added June 6 as a National Trails Day fee-free day, and Jasper, Alabama secured ~$893K for flood prevention.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
